Literature DB >> 31609245

Increased flux through the mevalonate pathway mediates fibrotic repair without injury.

Jennifer L Larson-Casey1, Mudit Vaid1, Linlin Gu1, Chao He1, Guo-Qiang Cai1, Qiang Ding1, Dana Davis1, Taylor F Berryhill2, Landon S Wilson2, Stephen Barnes2, Jeffrey D Neighbors3,4,5, Raymond J Hohl3,4,5, Kurt A Zimmerman6, Bradley K Yoder6, Ana Leda F Longhini7, Vidya Sagar Hanumanthu7, Ranu Surolia1, Veena B Antony1, A Brent Carter1,8.   

Abstract

Macrophages are important in mounting an innate immune response to injury as well as in repair of injury. Gene expression of Rho proteins is known to be increased in fibrotic models; however, the role of these proteins in idiopathic pulmonary fibrosis (IPF) is not known. Here, we show that BAL cells from patients with IPF have a profibrotic phenotype secondary to increased activation of the small GTPase Rac1. Rac1 activation requires a posttranslational modification, geranylgeranylation, of the C-terminal cysteine residue. We found that by supplying more substrate for geranylgeranylation, Rac1 activation was substantially increased, resulting in profibrotic polarization by increasing flux through the mevalonate pathway. The increased flux was secondary to greater levels of acetyl-CoA from metabolic reprogramming to β oxidation. The polarization mediated fibrotic repair in the absence of injury by enhancing macrophage/fibroblast signaling. These observations suggest that targeting the mevalonate pathway may abrogate the role of macrophages in dysregulated fibrotic repair.

Entities:  

Keywords:  Fibrosis; Immunology; Mitochondria; Monocytes; Pulmonology

Mesh:

Substances:

Year:  2019        PMID: 31609245      PMCID: PMC6819144          DOI: 10.1172/JCI127959

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   19.456


  57 in total

1.  Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis.

Authors:  N Kaminski; J D Allard; J F Pittet; F Zuo; M J Griffiths; D Morris; X Huang; D Sheppard; R A Heller
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

2.  Role for RhoB and PRK in the suppression of epithelial cell transformation by farnesyltransferase inhibitors.

Authors:  Ping-Yao Zeng; Neena Rane; Wei Du; Janaki Chintapalli; George C Prendergast
Journal:  Oncogene       Date:  2003-02-27       Impact factor: 9.867

3.  Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro.

Authors:  A Carano; S L Teitelbaum; J D Konsek; P H Schlesinger; H C Blair
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

4.  Differential expression of Na-K-ATPase isoforms in rat alveolar epithelial cells.

Authors:  K M Ridge; D H Rutschman; P Factor; A I Katz; A M Bertorello; J L Sznajder
Journal:  Am J Physiol       Date:  1997-07

5.  RhoA signaling in cardiomyocytes protects against stress-induced heart failure but facilitates cardiac fibrosis.

Authors:  Jessica Lauriol; Kimberly Keith; Fabrice Jaffré; Anthony Couvillon; Abdel Saci; Sanjeewa A Goonasekera; Jason R McCarthy; Chase W Kessinger; Jianxun Wang; Qingen Ke; Peter M Kang; Jeffery D Molkentin; Christopher Carpenter; Maria I Kontaridis
Journal:  Sci Signal       Date:  2014-10-21       Impact factor: 8.192

6.  Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages.

Authors:  Elizabeth F Redente; Rebecca C Keith; William Janssen; Peter M Henson; Luis A Ortiz; Gregory P Downey; Donna L Bratton; David W H Riches
Journal:  Am J Respir Cell Mol Biol       Date:  2014-04       Impact factor: 6.914

7.  Rac1 deletion in mouse neutrophils has selective effects on neutrophil functions.

Authors:  Michael Glogauer; Christophe C Marchal; Fei Zhu; Aelaf Worku; Björn E Clausen; Irmgard Foerster; Peter Marks; Gregory P Downey; Mary Dinauer; David J Kwiatkowski
Journal:  J Immunol       Date:  2003-06-01       Impact factor: 5.422

8.  Blockade of protein geranylgeranylation inhibits Cdk2-dependent p27Kip1 phosphorylation on Thr187 and accumulates p27Kip1 in the nucleus: implications for breast cancer therapy.

Authors:  Aslamuzzaman Kazi; Adam Carie; Michelle A Blaskovich; Cynthia Bucher; Van Thai; Stacy Moulder; Hairuo Peng; Dora Carrico; Erin Pusateri; Warren J Pledger; Norbert Berndt; Andrew Hamilton; Saïd M Sebti
Journal:  Mol Cell Biol       Date:  2009-02-09       Impact factor: 4.272

9.  Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis.

Authors:  Martina Korfei; Clemens Ruppert; Poornima Mahavadi; Ingrid Henneke; Philipp Markart; Miriam Koch; Gyoergy Lang; Ludger Fink; Rainer-Maria Bohle; Werner Seeger; Timothy E Weaver; Andreas Guenther
Journal:  Am J Respir Crit Care Med       Date:  2008-07-17       Impact factor: 21.405

10.  A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

Authors:  Talmadge E King; Williamson Z Bradford; Socorro Castro-Bernardini; Elizabeth A Fagan; Ian Glaspole; Marilyn K Glassberg; Eduard Gorina; Peter M Hopkins; David Kardatzke; Lisa Lancaster; David J Lederer; Steven D Nathan; Carlos A Pereira; Steven A Sahn; Robert Sussman; Jeffrey J Swigris; Paul W Noble
Journal:  N Engl J Med       Date:  2014-05-18       Impact factor: 91.245

View more
  12 in total

1.  Cadmium-mediated lung injury is exacerbated by the persistence of classically activated macrophages.

Authors:  Jennifer L Larson-Casey; Linlin Gu; Oliver Fiehn; A Brent Carter
Journal:  J Biol Chem       Date:  2020-09-11       Impact factor: 5.157

2.  Could a prostate drug be repurposed for Parkinson disease?

Authors:  Heather Wood
Journal:  Nat Rev Neurol       Date:  2019-11       Impact factor: 42.937

Review 3.  Mitochondrial quality control in pulmonary fibrosis.

Authors:  Jennifer L Larson-Casey; Chao He; A Brent Carter
Journal:  Redox Biol       Date:  2020-01-08       Impact factor: 11.799

Review 4.  Exploring the Role of ATP-Citrate Lyase in the Immune System.

Authors:  Monica Dominguez; Bernhard Brüne; Dmitry Namgaladze
Journal:  Front Immunol       Date:  2021-02-18       Impact factor: 7.561

5.  Targeting Cpt1a-Bcl-2 interaction modulates apoptosis resistance and fibrotic remodeling.

Authors:  Ranu Surolia; Jennifer L Larson-Casey; Linlin Gu; Chao He; Dana Davis; Jungsoon Kang; Veena B Antony; A Brent Carter
Journal:  Cell Death Differ       Date:  2021-08-20       Impact factor: 15.828

Review 6.  Mitochondria dysfunction and metabolic reprogramming as drivers of idiopathic pulmonary fibrosis.

Authors:  Marta Bueno; Jazmin Calyeca; Mauricio Rojas; Ana L Mora
Journal:  Redox Biol       Date:  2020-03-19       Impact factor: 11.799

7.  C(C)Learing the Role of Chemokines in Pulmonary Fibrosis.

Authors:  Chao He; A Brent Carter
Journal:  Am J Respir Cell Mol Biol       Date:  2020-05       Impact factor: 6.914

8.  Human menstrual blood-derived stem cells mitigate bleomycin-induced pulmonary fibrosis through anti-apoptosis and anti-inflammatory effects.

Authors:  Xin Chen; Yi Wu; Yanling Wang; Lijun Chen; Wendi Zheng; Sining Zhou; Huikang Xu; Yifei Li; Li Yuan; Charlie Xiang
Journal:  Stem Cell Res Ther       Date:  2020-11-11       Impact factor: 6.832

9.  Technical advance: The use of tree shrews as a model of pulmonary fibrosis.

Authors:  Jennifer L Larson-Casey; Chao He; Pulin Che; Meimei Wang; Guoqiang Cai; Young-Il Kim; Mustapha El Hamdaoui; Rafael Grytz; Qiang Ding; A Brent Carter
Journal:  PLoS One       Date:  2020-11-03       Impact factor: 3.240

10.  Post-translational regulation of PGC-1α modulates fibrotic repair.

Authors:  Jennifer L Larson-Casey; Linlin Gu; Dana Davis; Guo-Qiang Cai; Qiang Ding; Chao He; A Brent Carter
Journal:  FASEB J       Date:  2021-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.